Motoyasu Saji
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, Thyroid Disorders and Treatments, Cancer-related Molecular Pathways, PI3K/AKT/mTOR signaling in cancer, Growth Hormone and Insulin-like Growth Factors
Most-Cited Works
- → Phase II Trial of Sorafenib in Metastatic Thyroid Cancer(2009)543 cited
- → Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer(2010)374 cited
- → Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia(2005)320 cited
- → Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion(2007)309 cited
- → Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers(2011)304 cited
- Overexpression and overactivation of Akt in thyroid carcinoma.(2001)
- → Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies.(1990)226 cited
- → The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors(2009)184 cited
- → The Thyrotropin Receptor(1995)169 cited
- → Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination(2005)158 cited